Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Elshenawy MohamedCTO |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $226K 7,954 sh | Sep 17, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Elshenawy MohamedCTO | HIMSHims & Hers Health, Inc. Open-market sale · 10b5-1 plan | SELL | $226K 7,954 sh | Sep 17, 2026 |
| 22 | Hutchinson Michael DChief Operating Officer |  TDCTERADATA CORP /DE/Open-market sale · 10b5-1 plan | SELL | $1.44M 48.1K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 22 | A-6684 Ltd.10% Owner |  TOFBTOFUTTI BRANDS INCOpen-market purchase | BUY | $3,400 10.0K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 22 | Chi MichaelChief Operating Officer | HIMSHims & Hers Health, Inc. Open-market sale · 10b5-1 plan | SELL | $398K 14.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Verma ShivChief Financial Officer |  HOODRobinhood Markets, Inc.Open-market sale · 10b5-1 plan | SELL | $202K 1,800 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Inrig JulaEVP, Head of R&D & CMO |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.08M 17.3K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.30M 20.7K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Verma ShivChief Financial Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $202K 1,851 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Calvin SandraSVP, CHIEF ACCOUNTING OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $266K 4,275 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Verma ShivChief Financial Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $143K 1,289 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.70M 27.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.57M 25.4K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 20 |  David J. TaylorRSelf |  IBPInstalled Building Products, Inc.Purchase | BUY | $1,001 – $15K | Sep 17, 2026 traded Sep 8, 2026 |
| 20 |  Scott FranklinRSpouse |  JPMJPMORGAN CHASE & COPartial sale | SELL | $1,001 – $15K | Sep 17, 2026 traded Aug 20, 2026 |
| 20 | Scott FranklinRSelf | JPMJPMORGAN CHASE & CO Partial sale | SELL | $1,001 – $15K | Sep 17, 2026 traded Aug 20, 2026 |
| 20 | David J. TaylorRSelf |  PGPROCTER & GAMBLE CoPurchase | BUY | $1,001 – $15K | Sep 17, 2026 traded Sep 8, 2026 |
| 20 | Jergensen JoshuaPresident & COO |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $1.57M 36.5K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 19 | Boughton SoleilChief Legal Officer | HIMSHims & Hers Health, Inc. Open-market sale · 10b5-1 plan | SELL | $174K 6,236 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 18 | Verma ShivChief Financial Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $23K 200 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 18 | Verma ShivChief Financial Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 300 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 17 | Kenneweg JohnSVP, Sales & Product Marketing |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $216K 21.4K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 16 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $74K 2,025 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 16 | Kirchhoff Benjamin LouisCHIEF ACCOUNTING OFFICER |  IOTSamsara Inc.Open-market sale · 10b5-1 plan | SELL | $92K 2,165 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 16 | Turner Michael S.Chief Legal Officer |  HAWKHawkEye 360, Inc.Open-market sale · 10b5-1 plan | SELL | $296K 18.3K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 16 | Mensinger MikeChief Product Officer |  BBNXBeta Bionics, Inc.Open-market sale · 10b5-1 plan | SELL | $58K 2,650 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 14 | Calvin SandraSVP, CHIEF ACCOUNTING OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $50K 800 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 14 | Oey Peter HenryChief Financial Officer |  GRABGrab Holdings LtdOpen-market sale · 10b5-1 plan | SELL | $145K 50.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 14 | Misra AmitabhChief Technology Officer |  CXMSprinklr, Inc.Open-market sale · 10b5-1 plan | SELL | $229K 40.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 14 | Hanson Scott McLeanDirector, Chief Technology Officer |  AMBQAmbiq Micro, Inc.Open-market sale · 10b5-1 plan | SELL | $300K 4,947 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 14 | Gage BrodieEVP & Chief Product & |  CIENCIENA CORPOpen-market sale · 10b5-1 plan | SELL | $390K 1,200 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 14 | Remer Eric RichardDirector |  EVCMEverCommerce Inc.Open-market sale | SELL | $4,266 533 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 14 | Remer Eric RichardDirector | EVCMEverCommerce Inc. Open-market sale | SELL | $2,064 258 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 14 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Open-market sale | SELL | $519 18 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 14 | Jergensen JoshuaPresident & COO | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $153K 3,498 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 13 | McClymont DonaldDirector, Chief Executive Officer |  INDIindie Semiconductor, Inc.Open-market sale · 10b5-1 plan | SELL | $155K 50.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 13 | Turner Michael S.Chief Legal Officer | HAWKHawkEye 360, Inc. Open-market sale · 10b5-1 plan | SELL | $134K 8,250 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 13 | Holme TimothyCHIEF TECHNOLOGY OFFICER |  QSQuantumScape CorpOpen-market sale · 10b5-1 plan | SELL | $114K 22.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 13 | Holme TimothyCHIEF TECHNOLOGY OFFICER | QSQuantumScape Corp Open-market sale · 10b5-1 plan | SELL | $114K 22.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $102K 1,600 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $121K 1,900 sh | Sep 17, 2026 traded Sep 15, 2026 |